17th Apr 2019 18:11
LONDON (Alliance News) - Shield Therapeutics PLC said Wednesday Chair James Karis bought 50,000 shares in the company.
Karis acquired 46,000 shares at GBP0.815 on Monday, then acquired a further 4,000 at GBP0.81 on Tuesday, for a total of GBP40,730.
Karis now holds an interest in 86,667 shares, which represents 0.001% of Shield Therapeutics' entire issued share capital.
Shares in Shield Therapeutics closed down 1.3% Wednesday at 77.50p each.
Related Shares:
Shield Thera